PPIA and lung cancer: Numerous studies have demonstrated that CypA and its receptor CD147 are overexpressed in many cancers, including lung cancer, and that the activation of CypA/CD147-mediated intracellular downstream signaling pathways promotes the growth, metastasis, therapeutic resistance, and stem-like properties of cancer cells [14].